PortfoliosLab logoPortfoliosLab logo
SGRY vs. NHC
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

SGRY vs. NHC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Surgery Partners, Inc. (SGRY) and National HealthCare Corporation (NHC). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, SGRY achieves a -12.56% return, which is significantly lower than NHC's 36.54% return. Over the past 10 years, SGRY has underperformed NHC with an annualized return of -0.48%, while NHC has yielded a comparatively higher 14.69% annualized return.


SGRY

1D
-1.89%
1M
-4.86%
YTD
-12.56%
6M
-20.72%
1Y
-41.97%
3Y*
-30.23%
5Y*
-25.92%
10Y*
-0.48%

NHC

1D
1.69%
1M
9.28%
YTD
36.54%
6M
36.58%
1Y
81.64%
3Y*
47.80%
5Y*
23.95%
10Y*
14.69%
*Multi-year figures are annualized to reflect compound growth (CAGR)

SGRY vs. NHC - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
SGRY
Surgery Partners, Inc.
-12.56%-27.02%-33.82%14.82%-47.84%84.11%85.31%59.91%-19.09%-23.66%
NHC
National HealthCare Corporation
36.54%30.34%19.05%60.84%-9.42%5.39%-20.66%13.02%32.43%-17.26%

Correlation

The correlation between SGRY and NHC is 0.25, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.25

Correlation (3Y)
Calculated over the trailing 3-year period

0.26

Correlation (5Y)
Calculated over the trailing 5-year period

0.29

Correlation (10Y)
Calculated over the trailing 10-year period

0.29

Correlation (All Time)
Calculated using the full available price history since Oct 2, 2015

0.28

Fundamentals

Market Cap

SGRY:

$1.73B

NHC:

$2.94B

EPS

SGRY:

-$0.60

NHC:

$7.89

PS Ratio

SGRY:

0.51

NHC:

1.93

PB Ratio

SGRY:

1.03

NHC:

2.70

Total Revenue (TTM)

SGRY:

$3.34B

NHC:

$1.51B

Gross Profit (TTM)

SGRY:

$763.30M

NHC:

$558.31M

EBITDA (TTM)

SGRY:

$787.20M

NHC:

$204.52M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

SGRY vs. NHC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SGRY
SGRY Risk / Return Rank: 99
Overall Rank
SGRY Sharpe Ratio Rank: 77
Sharpe Ratio Rank
SGRY Sortino Ratio Rank: 1010
Sortino Ratio Rank
SGRY Omega Ratio Rank: 88
Omega Ratio Rank
SGRY Calmar Ratio Rank: 1010
Calmar Ratio Rank
SGRY Martin Ratio Rank: 88
Martin Ratio Rank

NHC
NHC Risk / Return Rank: 9292
Overall Rank
NHC Sharpe Ratio Rank: 9292
Sharpe Ratio Rank
NHC Sortino Ratio Rank: 9191
Sortino Ratio Rank
NHC Omega Ratio Rank: 8989
Omega Ratio Rank
NHC Calmar Ratio Rank: 9494
Calmar Ratio Rank
NHC Martin Ratio Rank: 9494
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SGRY vs. NHC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Surgery Partners, Inc. (SGRY) and National HealthCare Corporation (NHC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


SGRYNHCDifference

Sharpe ratio

Return per unit of total volatility

-0.91

2.57

-3.48

Sortino ratio

Return per unit of downside risk

-1.09

3.42

-4.51

Omega ratio

Gain probability vs. loss probability

0.83

1.42

-0.58

Calmar ratio

Return relative to maximum drawdown

-0.81

6.25

-7.06

Martin ratio

Return relative to average drawdown

-1.41

16.76

-18.17

SGRY vs. NHC - Sharpe Ratio Comparison

The current SGRY Sharpe Ratio is -0.91, which is lower than the NHC Sharpe Ratio of 2.57. The chart below compares the historical Sharpe Ratios of SGRY and NHC, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


SGRYNHCDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.91

2.57

-3.48

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.48

0.87

-1.34

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.01

0.52

-0.53

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.04

0.25

-0.29

Drawdowns

SGRY vs. NHC - Drawdown Comparison

The maximum SGRY drawdown since its inception was -82.86%, smaller than the maximum NHC drawdown of -96.33%. Use the drawdown chart below to compare losses from any high point for SGRY and NHC.


Loading charts...

Drawdown Indicators


SGRYNHCDifference

Max Drawdown

Largest peak-to-trough decline

-82.86%

-96.33%

+13.47%

Max Drawdown (1Y)

Largest decline over 1 year

-51.80%

-13.13%

-38.67%

Max Drawdown (3Y)

Largest decline over 3 years

-74.52%

-33.40%

-41.12%

Max Drawdown (5Y)

Largest decline over 5 years

-82.86%

-33.40%

-49.46%

Max Drawdown (10Y)

Largest decline over 10 years

-82.86%

-35.27%

-47.59%

Current Drawdown

Current decline from peak

-79.85%

-6.55%

-73.30%

Average Drawdown

Average peak-to-trough decline

-41.55%

-26.43%

-15.12%

Ulcer Index

Depth and duration of drawdowns from previous peaks

29.84%

4.89%

+24.95%

Volatility

SGRY vs. NHC - Volatility Comparison

The current volatility for Surgery Partners, Inc. (SGRY) is 9.69%, while National HealthCare Corporation (NHC) has a volatility of 13.02%. This indicates that SGRY experiences smaller price fluctuations and is considered to be less risky than NHC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


SGRYNHCDifference

Volatility (1M)

Calculated over the trailing 1-month period

9.69%

13.02%

-3.33%

Volatility (6M)

Calculated over the trailing 6-month period

28.92%

25.41%

+3.51%

Volatility (1Y)

Calculated over the trailing 1-year period

46.42%

31.93%

+14.49%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

54.68%

27.73%

+26.95%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

64.75%

28.19%

+36.56%

Dividends

SGRY vs. NHC - Dividend Comparison

SGRY has not paid dividends to shareholders, while NHC's dividend yield for the trailing twelve months is around 1.37%.


PositionTTM20252024202320222021202020192018201720162015
NHC
National HealthCare Corporation
1.37%1.85%2.25%2.53%3.80%3.11%3.13%2.38%2.52%3.10%2.31%3.14%
SGRY
Surgery Partners, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

SGRY vs. NHC - Financials Comparison

This section allows you to compare key financial metrics between Surgery Partners, Inc. and National HealthCare Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


200.00M300.00M400.00M500.00M600.00M700.00M800.00M900.00M20222023202420252026
810.90M
369.81M
(SGRY) Total Revenue
(NHC) Total Revenue
Values in USD except per share items

SGRY vs. NHC - Profitability Comparison

The chart below illustrates the profitability comparison between Surgery Partners, Inc. and National HealthCare Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%10.0%20.0%30.0%40.0%50.0%60.0%70.0%20222023202420252026
19.8%
0
Portfolio components
SGRY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Surgery Partners, Inc. reported a gross profit of 160.20M and revenue of 810.90M. Therefore, the gross margin over that period was 19.8%.

NHC - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, National HealthCare Corporation reported a gross profit of 0.00 and revenue of 369.81M. Therefore, the gross margin over that period was 0.0%.

SGRY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Surgery Partners, Inc. reported an operating income of 65.80M and revenue of 810.90M, resulting in an operating margin of 8.1%.

NHC - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, National HealthCare Corporation reported an operating income of 32.25M and revenue of 369.81M, resulting in an operating margin of 8.7%.

SGRY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Surgery Partners, Inc. reported a net income of -35.90M and revenue of 810.90M, resulting in a net margin of -4.4%.

NHC - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, National HealthCare Corporation reported a net income of 35.86M and revenue of 369.81M, resulting in a net margin of 9.7%.


Frequently Asked Questions


SGRY and NHC have a correlation of 0.25, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

NHC has higher volatility (13.02%) compared to SGRY (9.69%). In terms of maximum drawdown, SGRY dropped -82.86% vs NHC's -96.33%.

NHC currently has the higher Sharpe Ratio (2.57 vs -0.91), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for SGRY and NHC

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer